Cleared Traditional

K921512 - ENTENDED LINE ACCESSORIES & CONNECTORS (FDA 510(k) Clearance)

Class I Anesthesiology device.

K921512 · Intersurgical, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1992
Decision
85d
Days
Class 1
Risk

K921512 is an FDA 510(k) clearance for the ENTENDED LINE ACCESSORIES & CONNECTORS. Classified as Connector, Airway (extension) (product code BZA), Class I - General Controls.

Submitted by Intersurgical, Inc. (Cazenovia, US). The FDA issued a Cleared decision on June 17, 1992 after a review of 85 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5810 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Intersurgical, Inc. devices

Submission Details

510(k) Number K921512 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 24, 1992
Decision Date June 17, 1992
Days to Decision 85 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 139d · This submission: 85d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code BZA Connector, Airway (extension)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 868.5810
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.